Merck
CN
Search Within

S5393

Applied Filters:
Keyword:'S5393'
Showing 1-17 of 17 results for "S5393" within Papers
Thorunn A Olafsdottir et al.
Frontiers in immunology, 8, 1872-1872 (2018-01-24)
Influenza vaccination remains the best strategy for the prevention of influenza virus-related disease and reduction of disease severity and mortality. However, there is large individual variation in influenza vaccine responses. In this study, we investigated the effects of gender, age
Livia Mazzini et al.
Journal of immunological methods, 489, 112937-112937 (2020-12-01)
A newly identified coronavirus, named SARS-CoV-2, emerged in December 2019 in Hubei Province, China, and quickly spread throughout the world; so far, it has caused more than 49.7 million cases of disease and 1,2 million deaths. The diagnosis of SARS-CoV-2
Fabrizio Biuso et al.
Influenza and other respiratory viruses, 13(5), 504-516 (2019-08-15)
Formulation of neuraminidase (NA) within influenza vaccines is gaining importance in light of recent human studies. The enzyme-linked lectin assay (ELLA) is considered a reliable assay to evaluate human anti-NA antibodies. To overcome interference by hemagglutinin (HA)-specific antibodies and detect
R E Biagini et al.
Occupational and environmental medicine, 61(8), 703-708 (2004-07-20)
To evaluate potential exposure to Bacillis anthracis (Ba) spores in sampling/decontamination workers in the aftermath of an anthrax terror attack. Fifty six serum samples were obtained from workers involved in environmental sampling for Ba spores at the American Media, Inc.
Karina Jawinski et al.
Frontiers in immunology, 10, 2661-2661 (2019-12-05)
Current influenza vaccines manufactured using eggs have considerable limitations, both in terms of scale up production and the potential impact passaging through eggs can have on the antigenicity of the vaccine virus strains. Alternative methods of manufacture are required, particularly
Raymond E Biagini et al.
Clinical and diagnostic laboratory immunology, 10(5), 744-750 (2003-09-11)
We describe a fluorescent covalent microsphere immunoassay (FCMIA) method for the simultaneous (multiplexed) measurement of immunoglobulin G (IgG) antibodies to 23 pneumococcal capsular polysaccharide (PnPS) serotypes present in the pneumococcal polysaccharide vaccine (PPV23) licensed by the Food and Drug Administration
Joanna Waldock et al.
mSphere, 6(4), e0056721-e0056721 (2021-07-29)
The hemagglutination inhibition (HAI) assay is an established technique for assessing influenza immunity, through measurement of antihemagglutinin antibodies. Improved reproducibility of this assay is required to provide meaningful data across different testing laboratories. This study assessed the impact of harmonizing
Alessandro Manenti et al.
Journal of medical virology, 92(10), 2096-2104 (2020-05-10)
The micro-neutralization assay is a fundamental test in virology, immunology, vaccine assessment, and epidemiology studies. Since the SARS-CoV-2 outbreak at the end of December 2019 in China, it has become extremely important to have well-established and validated diagnostic and serological
Claudia Maria Trombetta et al.
Influenza and other respiratory viruses, 12(6), 675-686 (2018-07-19)
The immunological response to influenza vaccine and/or natural infection is evaluated by serological techniques, the most common being hemagglutination inhibition (HI), single radial hemolysis (SRH), and virus neutralization assays, which is commonly used in a micro-neutralization (MN) format. ELISA is
Use of lentiviral pseudotypes as an alternative to reassortant or Triton X-100-treated wild-type Influenza viruses in the neuraminidase inhibition enzyme-linked lectin assay
Biuso F, et al.
Influenza and Other Respiratory Viruses, 13(5), 504-516 (2019)
Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses
Trombetta CM, et al.
Journal of Immunological Methods, 422, 95-101 (2015)
Age and influenza-specific pre-vaccination antibodies strongly affect influenza vaccine responses in the Icelandic population whereas disease and medication have small effects
Olafsdottir TA, et al.
Frontiers in Immunology, 8, 1872-1872 (2018)
J C Schellenberg et al.
American journal of obstetrics and gynecology, 178(3), 535-539 (1998-04-16)
Our purpose was to determine whether the secretory component of immunoglobulin A in maternal serum predicts delivery before 34 weeks' gestation. Primigravid women of an urban population in New Zealand were recruited at booking into a prospective longitudinal nested case
Method for Simultaneous Measurement of Antibodies to 23 Pneumococcal Capsular Polysaccharides
Raymond E. Biagini, Sonela A. Schlottmann
Clinical and Vaccine Immunology : CVI, 10(5), 744-750 (2003)
Marie-Clotilde Bernard et al.
Frontiers in immunology, 13, 909297-909297 (2022-07-06)
Current vaccination strategies against influenza focus on generating an antibody response against the viral haemagglutination surface protein, however there is increasing interest in neuraminidase (NA) as a target for vaccine development. A critical tool for development of vaccines that target
Claudia M Trombetta et al.
Viruses, 12(1) (2020-01-02)
Influenza D virus is a novel influenza virus, which was first isolated from an ailing swine in 2011 and later detected in cattle, suggesting that these animals may be a primary natural reservoir. To date, few studies have been performed
Khin Myo Aye et al.
Journal of immunological methods, 462, 91-100 (2018-09-12)
Development of reliable, quantitative technologies for serodiagnosis of Toxoplasma gondii infection remains desirable. The luciferase immunoprecipitation system (LIPS) is a relatively simple, highly sensitive, and rapid quantitative immunoassay. The major advantages of this assay over ELISA are a wider dynamic
Page 1 of 1